Did you know …

That the density of Life Sciences activities per capita is three times higher in Belgium than it is in Germany ?

Wallonia, the southern region of Belgium, has naturally many things to offer when it comes to biotechnologies.

With its 5 universities,6 private research centers and 11,000 researcherspacked in a territory smaller than Saxony, the Walloon Life Sciences ecosystem is the best ecosystem to invest in !

There are many reasons to set up your German biotech company in Wallonia.

Here are some of them:

  • Wallonia is first in the EU for pharma R&D investment per capita (Belgium)
  • Belgium is second worldwide for clinical trials applications
  • It is second worldwide in Biopharma Talent Development
  • A vibrant ecosystem: more than 250 innovative SMEs are in Wallonia

for Pharma R&D investment 1st in EU for Pharma R&D investment

per inhabitant (Belgium)

for clinical trials applications 2d in the World for clinical trials applications

and fastest clinical application procedure

innovatives SMEs +250 innovatives SMEs

are based in the Wallonia's vibrant ecosystem

Why should you choose Wallonia ? 

  • A high number of R&D incentives help companies in Belgium to reinforce their potential
  • Wallonia is the biggest exporter of biopharmaceuticals
  • Global biopharma and Life Sciences leaders like GSK and UCB are on Walloon ground

Meet us at BIO-Europe !

Get in touch and let´s arrange an online meeting or real one at BIO-Europe in November !

I want to be contacted

Want to know more about Wallonia ?

The Wallonia Export & Investment Agency can assist you. Get in touch and let's arrange an online meeting or let's meet in person at BIO-Europe in november !

Ludovic WAHA

Project Manager - Italy - Switzerland - Luxembourg

T +32 (0)81 33 29 02

They chose Wallonia to invest in Life Sciences.

Why not do it too ?

Investment of €300 million by the Japanese TAKEDA group in Lessines

with a view to establishing a new production line for plasma-based therapies.

[ Read more ]

UCB announces a one billion euro investment in its Braine-l'Alleud campus

UCB, a major player in the biopharmaceutical sector, has announced a major investment programme in Wallonia.

[ Read more ]

GSK is investing €330 million in a freeze-drying unit for vaccines in Wavre

GlaxoSmithKline is continuing to develop its pharmaceutical activities in Wallonia at its site in Wavre.

[ Read more ]

misc.back to top back to top
Customize your browsing experience
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Quis ipsum suspendisse ultrices gravida.
Choisissez parmi les options ci-dessous.

Choisissez une option

Contactez-nous sur votre projet Contactez-nous via Messenger